Navigation Links
Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Merck's Generic Pharmaceutical Business
Date:8/31/2007

cribed in the Offer to Purchase and Consent Solicitation Statement.

The complete terms and conditions of the tender offers and consent solicitations are described in the Offer to Purchase and Consent Solicitation Statement and related Letter of Instructions, copies of which may be obtained by contacting Global Bondholder Services Corporation, the information agent for the tender offers and consent solicitations, at (866) 804-2200 (toll- free). Questions regarding the tender offers and consent solicitations may be directed to the Dealer Managers and Solicitation Agents for the tender offers and consent solicitations, Merrill Lynch, Pierce, Fenner & Smith Incorporated, which may be contacted at (212) 449-4914 (collect) or (888) 654-8637 (toll- free), and Citigroup Global Markets Inc., which may be contacted at (212) 723-6106 (collect) or (800) 558-3745 (toll-free).

This announcement is not an offer to purchase, a solicitation of an offer to purchase or a solicitation of consents with respect to any securities. The tender offers and consent solicitations are being made solely by Mylan's Offer to Purchase and Consent Solicitation Statement and the related Letter of Instructions dated August 31, 2007, as the same may be amended or supplemented by Mylan.


'/>"/>
SOURCE Mylan Laboratories Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. Natco Pharma Commences Production At Dehradun Unit
5. Pfizer Commences Its Advertising for Celebrex with All the Warnings
6. Chinas First Gay Health Clinic Commences Operations
7. Mental Health - NHS Trust Commences Specialist Transition Service
8. Surface Logix Commences Phase 2a Clinical Trial of SLx-2101 in Raynauds Disease
9. Trial of VivaGel in Sexually Active Young Women Commences
10. An unlikely contender for speedy surgery recovery: Chewing gum
11. Another contender for bird flu besides poultry; cats!
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4Jim Kerwin of Kerwin Communications Has Donated Over 2410 000 to Lavallette Charity Helping Hands Loving Hearts 50782 1Jim Kerwin of Kerwin Communications Has Donated Over 2410 000 to Lavallette Charity Helping Hands Loving Hearts 50782 2Delirium in hospitalized adults 3A Situation critical no relief available 50777 1Delirium in hospitalized adults 3A Situation critical no relief available 50777 2Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 50773 1Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 50773 2Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 50773 3